We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Chromadex Corp
10 own
13 watching
Current Price
$3.44
$0.05
(1.47%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
117.23M
52-Week High
4.65000
52-Week Low
1.25000
Average Volume
0.18M
Dividend Yield
--
P/E Ratio
--
Market Capitalization117.23M52-Week High4.6500052-Week Low1.25000Average Volume0.18MDividend Yield--P/E Ratio--What does the Chromadex Corp do?
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers, as well as to distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and IMMULINA, a Braun-type lipoproteins, including spirulina extracts and active compounds, which are used to support human immune function. It also offers analytical reference standards and services comprising supply of products to conduct quality control of raw materials and consumer products in dietary supplements, cosmetics, food and beverages, life sciences, and pharmaceutical industries. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation is headquartered in Los Angeles, California.
Read More
How much money does Chromadex Corp make?
News & Events about Chromadex Corp.
Business Wire
10 months ago
On June 13th, ChromaDex Corp. (NASDAQ:CDXC), a global authority on nicotinamide adenine dinucleotide (NAD+) research and healthy aging, celebrated the 10th anniversary of its award-winning ChromaDex External Research Program (CERP). Through CERP, independent scientists and investigators from some...
Zolmax
10 months ago
StockNews.com upgraded shares of ChromaDex (NASDAQ:CDXC Get Rating) from a buy rating to a strong-buy rating in a report published on Friday morning. Several other research analysts have also recently weighed in on CDXC. LADENBURG THALM/SH SH dropped their price target on shares of ChromaDex from $7...
Business Wire
1 year ago
ChromaDex Corp. (NASDAQ:CDXC) (the Company) a global bioscience company dedicated to healthy aging, today announced that senior management will participate at the 35th annual ROTH Capital Partners Conference at the Ritz-Carlton in Dana Point, CA. The Annual ROTH Conference is one of the largest in...
Business Wire
1 year ago
ChromaDex Corp. (NASDAQ:CDXC) (the Company), a global bioscience company dedicated to healthy aging, announced that it will hold a conference call on Wednesday, March 8, 2023 at 4:30 p.m. ET to discuss its financial results for the fourth quarter and fiscal year, which ended December 31, 2022. The...
Business Wire
1 year ago
ChromaDex Corp. (NASDAQ:CDXC), a global bioscience company dedicated to healthy aging, holds an exclusive license from Queens University Belfast for methods of making nicotinamide riboside (NR) and related derivatives, some of the most efficient nicotinamide adenine dinucleotide (NAD+) precursors...
Frequently Asked Questions
Frequently Asked Questions
What is Chromadex Corp share price today?
Can Indians buy Chromadex Corp shares?
How can I buy Chromadex Corp shares from India?
Can Fractional shares of Chromadex Corp be purchased?
What are the documents required to start investing in Chromadex Corp stocks?
What is today’s traded volume of Chromadex Corp?
What is today’s market capitalisation of Chromadex Corp?
What is the 52-Week High and Low Range of Chromadex Corp?
What percentage is Chromadex Corp down from its 52-Week High?
What percentage is Chromadex Corp up from its 52-Week Low?
Current Price
$3.44
$0.05
(1.47%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.